How The Largest Operator Of Dialysis Centers Kept Granuflo On The Market Even After Reports Of Patient Deaths

Fresenius Medical Care, the world's largest operator of dialysis centers, kept the toxic dialysate concentrate Granuflo on the market for years, even after it was linked to patient deaths.

Granuflo is a dialysate concentrate used to clean the blood of patients with kidney failure. It is made by Fresenius Medical Care.

GranuFlo: How the Largest Operator of Dialysis Centers Kept GranuFlo on the Market … Even After Reports of Consumer Harm Emerged

5 out of 5

Language	:	English
File size	:	861 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Word Wise	:	Enabled
Print length	:	27 pages
Lending	:	Enabled

FREE

In 2012, the FDA began receiving reports of patient deaths and other serious injuries linked to Granuflo. The FDA investigated and found that Granuflo was contaminated with a chemical called bicarbonate. Bicarbonate can cause a build-up of fluid in the lungs, which can lead to death.

Despite the FDA's findings, Fresenius Medical Care continued to sell Granuflo. The company claimed that the benefits of Granuflo outweighed the risks.

In 2014, the FDA issued a warning letter to Fresenius Medical Care. The FDA warned the company that it was violating the law by selling Granuflo without adequate warnings about the risks of the product.

In 2016, the FDA Free Downloaded Fresenius Medical Care to recall Granuflo. The company recalled the product, but it continued to sell it to some patients.

In 2017, the FDA issued a second warning letter to Fresenius Medical Care. The FDA warned the company that it was still violating the law by selling Granuflo without adequate warnings about the risks of the product.

In 2018, the FDA banned the sale of Granuflo. The FDA banned the product because it was linked to patient deaths and other serious injuries.

Fresenius Medical Care has settled lawsuits with patients who were injured or killed by Granuflo. The company has also paid millions of dollars in fines to the government.

The Granuflo scandal is a reminder of the importance of patient safety. It is also a reminder of the importance of holding companies accountable for their actions.

How Granuflo Was Linked to Patient Deaths

Granuflo was linked to patient deaths through a number of different mechanisms.

One way that Granuflo was linked to patient deaths is through the build-up of fluid in the lungs. Bicarbonate can cause a build-up of fluid in the lungs, which can lead to death.

Another way that Granuflo was linked to patient deaths is through the formation of blood clots. Bicarbonate can cause the formation of blood clots, which can block blood flow to the heart or brain.

Granuflo was also linked to patient deaths through the development of infections. Bicarbonate can suppress the immune system, which can make patients more susceptible to infections.

Fresenius Medical Care's Response to the Granuflo Scandal

Fresenius Medical Care has responded to the Granuflo scandal in a number of ways.

One way that Fresenius Medical Care has responded to the Granuflo scandal is by settling lawsuits with patients who were injured or killed by the product.

Another way that Fresenius Medical Care has responded to the Granuflo scandal is by paying millions of dollars in fines to the government.

Fresenius Medical Care has also taken steps to improve the safety of its products.

For example, Fresenius Medical Care has developed a new dialysate concentrate called Granuflo Plus. Granuflo Plus is not contaminated with bicarbonate.

Fresenius Medical Care has also implemented a number of new safety measures to prevent the sale of contaminated products.

The Importance of Patient Safety

The Granuflo scandal is a reminder of the importance of patient safety.

Patients should be able to trust that the products they are using are safe and effective.

Companies have a responsibility to make sure that their products are safe and effective.

The government has a responsibility to protect patients from unsafe products.

The Granuflo scandal is a reminder that we must all work together to protect patients from unsafe products.

Holding Companies Accountable

The Granuflo scandal is also a reminder of the importance of holding companies accountable for their actions.

Companies that put profits ahead of patient safety should be held accountable.

The government has a number of tools that it can use to hold companies accountable, including fines, lawsuits, and criminal prosecution.

The Granuflo scandal is a reminder that we must hold companies accountable for their actions.

The Granuflo scandal is a reminder of the importance of patient safety and the importance of holding companies accountable for their actions.

We must all work together to protect patients from unsafe products and to hold companies accountable for their actions.

GranuFlo: How the Largest Operator of Dialysis Centers Kept GranuFlo on the Market … Even After Reports of Consumer Harm Emerged

5 out of 5

Language	:	English
File size	:	861 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Word Wise	:	Enabled
Print length	:	27 pages
Lending	:	Enabled

FREE